This article has been updated to clarify CMS's initial determination on the reimbursement process for AMA's new molecular pathology test codes.

NEW YORK (GenomeWeb News) – The Centers for Medicare & Medicaid Services last week issued a preliminary decision to place new Current Procedural Terminology codes for molecular diagnostics that it determines fall under its clinical laboratory fee schedule to be reimbursed via the so-called "gapfill" process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.